Literature DB >> 16159844

Coronary artery bypass grafting in patients with low ejection fraction.

Veli K Topkara1, Faisal H Cheema, Satish Kesavaramanujam, Michelle L Mercando, Ayesha F Cheema, Pearila B Namerow, Michael Argenziano, Yoshifumi Naka, Mehmet C Oz, Barry C Esrig.   

Abstract

BACKGROUND: Patients with low ejection fraction (EF) are at a higher risk for postoperative complications and mortality. Our objective was to assess the effect of low EF on clinical outcomes after coronary artery bypass grafting (CABG). METHODS AND
RESULTS: We analyzed 55,515 patients from New York State database who underwent CABG between 1997 and 1999. Patients were stratified into 1 of the 4 EF groups: Group I (EF< or =20%), Group II (EF 21% to 30%), Group III (EF 31% to 40%), and Group IV (EF>40%). History of previous myocardial infarction, renal failure, and congestive heart failure were higher in patients with low EF (all P<0.001). Group I experienced a higher incidence of postoperative respiratory failure (10.1% versus 2.9%), renal failure (2.5% versus 0.6%), and sepsis (2.5% versus 0.6%) compared with Group IV. In-hospital mortality was significantly higher in Group I (6.5% versus 1.4%; P<0.001). Multivariate analysis showed hepatic failure [odds ratio (OR), 11.2], renal failure (OR, 4.1), previous myocardial infarction (OR, 3.4), reoperation (OR, 3.4), emergent procedures (OR, 3.2), female gender (OR, 1.7), congestive heart failure (OR, 1.6), and age (OR, 1.04) as independent predictors of in-hospital mortality in the low EF group. The discharges to home rate were significantly lower in Group I versus Group IV (73.1% and 87.7%, respectively; P<0.001).
CONCLUSIONS: Patients with low EF are sicker at baseline and have >4 times higher mortality than patients with high EF. However, outcomes are improving over time and are superior to historical data. Therefore, CABG remains a viable option in selected patients with low EF.

Entities:  

Mesh:

Year:  2005        PMID: 16159844     DOI: 10.1161/CIRCULATIONAHA.104.526277

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  36 in total

1.  Female gender and left ventricular dysfunction in myocardial surgical revascularization: the strange couple.

Authors:  Luigi Di Tommaso; Raffaele Giordano; Ettorino Di Tommaso; Gabriele Iannelli
Journal:  J Thorac Dis       Date:  2018-07       Impact factor: 2.895

2.  Postoperative complications after elective coronary artery bypass grafting surgery in patients with sleep-disordered breathing.

Authors:  Maria Tafelmeier; Teresa Weizenegger; Sarah Ripfel; Miriam Fauser; Bernhard Floerchinger; Daniele Camboni; York Zausig; Sigrid Wittmann; Marzena A Drzymalski; Florian Zeman; Christof Schmid; Lars S Maier; Stefan Wagner; Michael Arzt
Journal:  Clin Res Cardiol       Date:  2018-06-12       Impact factor: 5.460

3.  Is severely left ventricular dysfunction a predictor of early outcomes in patients with coronary artery bypass graft?

Authors:  Seyed Hossein Ahmadi; Abbasali Karimi; Namvar Movahedi; Mahmood Shirzad; Mehrab Marzban; Mokhtar Tazik; Hermineh Aramin; Samaneh Dowlatshahi; Mahmood Sheikh Fathollahi
Journal:  Heart Asia       Date:  2010-07-29

Review 4.  Current outcomes of off-pump coronary artery bypass grafting: evidence from real world practice.

Authors:  Piroze M Davierwala
Journal:  J Thorac Dis       Date:  2016-11       Impact factor: 2.895

5.  Early risk of mortality after coronary artery revascularization in patients with left ventricular dysfunction and potential role of the wearable cardioverter defibrillator.

Authors:  Edwin T Zishiri; Sarah Williams; Edmond M Cronin; Eugene H Blackstone; Stephen G Ellis; Eric E Roselli; Nicholas G Smedira; A Marc Gillinov; Jo Ann Glad; Patrick J Tchou; Steven J Szymkiewicz; Mina K Chung
Journal:  Circ Arrhythm Electrophysiol       Date:  2012-12-28

6.  Long-term survival and functional recovery after isolated coronary artery bypass grafting in patients with severe left ventricular dysfunction.

Authors:  Toshihiro Fukui; Toshihiko Shibata; Yasuyuki Sasaki; Hidekazu Hirai; Manabu Motoki; Yosuke Takahashi; Atsushi Nakahira; Shigefumi Suehiro
Journal:  Gen Thorac Cardiovasc Surg       Date:  2007-10

7.  Preoperative ejection fraction as a predictor of survival after coronary artery bypass grafting: comparison with a matched general population.

Authors:  Mohamed A Soliman Hamad; Albert H M van Straten; Jacques P A M Schönberger; Joost F ter Woorst; Andre M de Wolf; Elisabeth J Martens; André A J van Zundert
Journal:  J Cardiothorac Surg       Date:  2010-04-23       Impact factor: 1.637

8.  The rationale and design of the Surgical Treatment for Ischemic Heart Failure (STICH) trial.

Authors:  Eric J Velazquez; Kerry L Lee; Christopher M O'Connor; Jae K Oh; Robert O Bonow; Gerald M Pohost; Arthur M Feldman; Daniel B Mark; Julio A Panza; George Sopko; Jean L Rouleau; Robert H Jones
Journal:  J Thorac Cardiovasc Surg       Date:  2007-12       Impact factor: 5.209

9.  Influence of Baseline Characteristics, Operative Conduct, and Postoperative Course on 30-Day Outcomes of Coronary Artery Bypass Grafting Among Patients With Left Ventricular Dysfunction: Results From the Surgical Treatment for Ischemic Heart Failure (STICH) Trial.

Authors:  Krzysztof Wrobel; Susanna R Stevens; Robert H Jones; Craig H Selzman; Andre Lamy; Thomas M Beaver; Ljubomir T Djokovic; Nan Wang; Eric J Velazquez; George Sopko; Irving L Kron; J Michael DiMaio; Robert E Michler; Kerry L Lee; Michael Yii; Chua Yeow Leng; Marian Zembala; Jean L Rouleau; Richard C Daly; Hussein R Al-Khalidi
Journal:  Circulation       Date:  2015-08-25       Impact factor: 29.690

10.  Extent of coronary and myocardial disease and benefit from surgical revascularization in ischemic LV dysfunction [Corrected].

Authors:  Julio A Panza; Eric J Velazquez; Lilin She; Peter K Smith; José C Nicolau; Roberto R Favaloro; Sinisa Gradinac; Lukasz Chrzanowski; Dorairaj Prabhakaran; Jonathan G Howlett; Marek Jasinski; James A Hill; Hanna Szwed; Robert Larbalestier; Patrice Desvigne-Nickens; Robert H Jones; Kerry L Lee; Jean L Rouleau
Journal:  J Am Coll Cardiol       Date:  2014-08-12       Impact factor: 24.094

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.